[1] Lespagnard L, Gancberg D, Rouas G, et al. Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome. Int J Cancer, 1999, 84:309-314. [2] Toriyama K, Wen DR, Paul E, et al. Variations in the distribution,frequency, and phenotype of Langerhans cells during the evolution of malignant melanoma of the skin. J Invest Dermatol, 1993, 100:269S-273S. [3] Thurnher M, Radmayr C, Ramoner R, et al. Human renal-cell carcinoma tissue contains dendritic cells. Int J Cancer, 1996, 68:1-7. [4] Bell D, Chomarat P, Broyles D, et al. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med, 1999, 190:1417-1426. [5] Pimpinelli N, Santucci M, Romagnoli P, et al. Dendritic cells in Tand B-cell proliferation in the skin. Dermatol Clin, 1994, 12:255-270. [6] Fivenson DP, Nickoloff BJ. Distinctive dendritic cell subsets expressing factor XIIIa, CD1a, CD1b and CD1c in mycosis fungoides and psoriasis. J Cutan Pathol, 1995, 22:223-228. [7] Willemze R, Kerl H, Sterry W, et al. EORTC classific ation for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood, 1997, 90:354-371. [8] Meissner K, Loning T, Rehpenning W. Epidermal Langerhans cells and prognosis of patients with mycosis fungoides and Sezary syndrome. In Vivo, 1993, 7:277-280. |